➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Baxter
Mallinckrodt
Medtronic
McKinsey

Last Updated: April 14, 2021

DrugPatentWatch Database Preview

Details for Patent: 5,840,722

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,840,722
Title: Use of carboxylic acid derivatives as drugs
Abstract:A method of inhibiting endothelin receptors by administering to a patient a compound of the formula I ##STR1##
Inventor(s): Baumann; Ernst (Dudenhofen, DE), Vogelbacher; Uwe Josef (Ludwigshafen, DE), Rheinheimer; Joachim (Ludwigshafen, DE), Klinge; Dagmar (Heidelberg, DE), Riechers; Hartmut (Ludwigshafen, DE), Kroger; Burkhard (Limburgerhof, DE), Bialojan; Siegfried (Oftersheim, DE), Bollschweiler; Claus (Heidelberg, DE), Wernet; Wolfgang (Hassloch, DE), Unger; Liliane (Ludwigshafen, DE), Raschack; Manfred (Weisenheim, DE)
Assignee: BASF Aktiengesellschaft (Ludwigshafen, DE)
Application Number:08/718,377
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,840,722

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,840,722

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany44 11 225.4Mar 31, 1994
PCT Information
PCT FiledMarch 23, 1995PCT Application Number:PCT/EP95/01099
PCT Publication Date:October 12, 1995PCT Publication Number: WO95/26716

International Family Members for US Patent 5,840,722

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 204471   Start Trial
Australia 2135695   Start Trial
Australia 695193   Start Trial
Brazil 9507231   Start Trial
Canada 2186784   Start Trial
China 1070701   Start Trial
China 1148807   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Harvard Business School
Baxter
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.